B. Douglas Hoey, RPh, MBA, Chief Executive Officer, National Community Pharmacists Association

home / authors / b-douglas-hoey-rph-mba-chief-executive-officer-national-community-pharmacists-association

Articles

Site Logo

The New Compounding Law and Community Pharmacy's Future

B. Douglas Hoey, RPh, MBA, Chief Executive Officer, National Community Pharmacists Association
January 16th 2014

Meaningful federal compounding legislation has been developed.

Read More

Site Logo

MTM Legislation Introduced in the US Senate and House of Representatives

B. Douglas Hoey, RPh, MBA, Chief Executive Officer, National Community Pharmacists Association
June 18th 2013

Recently introduced bills seek to expand counseling sessions with pharmacists for patients.

Read More

Site Logo

The Wave of the Future is Here-- Specialty Drugs

B. Douglas Hoey, RPh, MBA, Chief Executive Officer, National Community Pharmacists Association
May 30th 2013

Independent community pharmacists are well positioned to aid patients with specialty medications.

Read More

Site Logo

The Wave of the Future is Here--Specialty Drugs

B. Douglas Hoey, RPh, MBA, Chief Executive Officer, National Community Pharmacists Association
January 14th 2013

Independent community pharmacists are well positioned to aid patients with specialty medications.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders